To verify the expression pattern of FTO, we performed an immunohistochemical (IHC) staining assay to analyze its protein expression level in 240 paired tumor and adjacent normal tissues from SYSUCC CRC patients (Fig. 1E). The gene discussed is FTO; the disease is colorectal carcinoma.